Uroplasty participates in 9th Annual JMP Securities Healthcare Conference

Uroplasty, Inc. (NASDAQ: UPI) a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that it will participate in the 9th Annual JMP Securities Healthcare Conference on Tuesday, June 24.

Rob Kill, President and CEO, will present at 1:00pm ET and meet with investors one on one at the conference at The Westin New York Grand Central. Attendance at the conference is by invitation only. A live webcast of the presentation with accompanying slides will be broadcast via the Internet. Those interested in joining the webcast may access it through Uroplasty's website at www.uroplasty.com. An archived replay of the presentation will be available for 90 days following the event.